ArticleAlzheimer's & dementia (New York, N. Y.)2016

Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.

David Gelmont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.